Laboratory research material only. Not for human or animal consumption.
Home/Shop/NAD+ 1000mg
NAD+ 1000mg research peptide vial · Polaris Research

Energy & Longevity · 1000mg

NAD+ 1000mg

CAS 53-84-9

$179
Low stock, selling fast
1
#5 in monthly peptide rankings
Free Express Delivery, No Minimum
Quality Certificate Included
Card, PayPal or PayID
Sealed Under Argon
Reserved for 24h Once Ordered

NAD+, short for nicotinamide adenine dinucleotide (also written NAD or NAD plus), is a coenzyme central to cellular energy metabolism, studied for redox, mitochondrial, and healthy-ageing pathway research. Unlike the peptides in the catalogue, NAD+ is a dinucleotide cofactor rather than an amino-acid chain, and it is one of the most studied molecules in cellular-energy research. The high-capacity 1000mg vial is the standard format for this category.In preclinical and in-vitro research, NAD+ is investigated for its role in the redox reactions that power cellular metabolism and for the mitochondrial and sirtuin-signalling pathways associated with cellular ageing. Because it sits at the centre of energy metabolism, it is studied across a wide range of cellular models, which is what makes it a reference molecule for the longevity and cellular-energy family.Researchers studying cellular-energy and longevity pathways sometimes look at NAD+ alongside other members of the energy-and-longevity range, such as Glutathione and SS-31; our NAD+ and cellular energy library guide goes deeper into the pathways it is studied for. The 1000mg vial provides ample material for extended cellular-energy investigation.Every 1000mg vial ships lyophilised with an independently verified batch certificate at a guaranteed floor of ≥98% purity, verifiable on the batch verification page using the batch number on the label. Reconstitute with bacteriostatic water: add it slowly down the inside wall of the vial, swirl gently, and never shake. Store the unopened vial at 2 to 8°C; refrigerate the reconstituted solution and avoid repeated freeze-thaw cycles. CAS reference 53-84-9.Buying NAD+ in Australia is domestic and direct: free Australia Post Express shipping Australia-wide with no minimum spend, dispatch from within Australia, and tracking on every parcel. Pay by card, PayPal, or PayID; each vial is sealed under argon with a 24-hour payment reservation on your stock. Supplied strictly as a research material for lawful laboratory and in-vitro use, not for human or veterinary consumption.

Formal Name
Nicotinamide Adenine Dinucleotide
CAS Number
53-84-9
Purity
99.6% · batch-tested
Description
Nicotinamide adenine dinucleotide is a central redox coenzyme involved in cellular energy metabolism, DNA repair and signalling enzymes.
Research Focus
Cellular-energy, redox, mitochondrial and healthy-ageing pathway research.
Suggested Use
Reference plan: 100 mg aliquots once daily or as specified by a short 8 to 12 week study block.
Doses per Vial
10 x 100 mg reference aliquots.
Concentration
100 mg per reference aliquot from a 1000 mg vial.
Notes
NAD+ handling is preparation-sensitive; avoid heat and prolonged storage after preparation.
Monthly Ranking

#5 most popular research peptide

View ranking

NAD+ carries 3,067 indexed publications, 204 registered trials, 2 with Australian sites, 13,685 monthly readers on Wikipedia. Research activity sits at 337 papers in the past twelve months against 282 the year before.

Why It's Searched

Longevity and cellular-energy searches with a lower barrier for new peptide buyers.

Evidence Standing

3,067 papers, 337 this year · 204 trials, 2 in Australia · 13,685 readers (-8%) · B tier

NAD peptide AustraliaNAD+ 1000mglongevity peptides Australiacellular energy research
Updated 2 August 2026

Prepared with care, sealed under argon, and stored at 2–8°C until dispatch. Reconstitute with Bacteriostatic Water before use. Full preparation and storage guidance included with your order.

Independent Research
Evidence Overview on reptides.co

Independent third-party research on reptides.co — not affiliated with Polaris Research. Research reference only, not medical advice.

Pairs Well With

Complete your order

Related Reading

From the library

Also Searched As·NAD+ is also searched as NAD+, NAD, Nicotinamide adenine dinucleotide, β-NAD, NAD plus, NAD peptide.

Research File

What has been published on NAD+

Steady

NAD+ appears in 3,067 indexed publications going back to 2017, including 337 in the past twelve months. 204 registered trials appear on ClinicalTrials.gov, 2 with Australian sites.

3,067
Indexed publications
337
Past 12 months
204 (2 AU)
Registered trials
13,685
Monthly readers, down 8%
20152026

Publications per year. The final bar is the current year, still in progress.

Indexed publications per year
20150
20160
20173
20186
201918
202034
202159
2022109
2023130
2024199
2025232
2026210
Read the full NAD+ research fileCounts from Europe PMC and ClinicalTrials.gov, refreshed weekly. Reported as a record of what exists, not as evidence of any effect.